U.S. Markets closed

KBR Arm to Build Oral Solid Dosage Plant for Prudue Pharma

Zacks Equity Research

KBR Ltd’s (KBR) Services Group subsidiary has signed a deal with Prudue Pharma Manufacturing L.P. for the construction of an 188,000-square-foot steel-framed Oral Solid Dosage manufacturing plant on a 51-acre site in Treyburn Corporate Park, Durham. Although the financial details of the deal were not disclosed, the estimated revenues will be included in KBR’s first-quarter 2014 backlog of unfilled orders under the Services segment.

The proposed facility will feature clean room spaces with epoxy flooring, painted walls and ceilings. The building will also house administrative offices, laboratories and associated support areas assigned for dining, conference, and training.

KBR’s Services Group delivers full-scope construction, construction management, fabrication, operations/maintenance, commissioning/startup and turnaround expertise worldwide to a broad variety of markets including oil and gas, petrochemicals processing, mining, power, alternate energy, pulp and paper, industrial and manufacturing and consumer product industries. The services offered are organized around four major product lines which include U.S. Construction, Industrial Services, Building Group and Canada Operations. The division accounted for 28.2% of the total revenue in fiscal 2013. In the last reported quarter (first quarter 2014), the Services segment reported a 10.4% decline in revenues owing to losses incurred in the fabrication and module assembly projects in Canada.

KBR is a global engineering, construction and services company and currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the sector include Altra Holdings Inc. (AIMC), Nordson Corp. (NDSN) and Twin Disc (TWIN). All three hold a Zacks Rank #2 (Buy).

Read the Full Research Report on KBR
Read the Full Research Report on NDSN
Read the Full Research Report on AIMC
Read the Full Research Report on TWIN

Zacks Investment Research